Organogenesis
Price & Volume
Stats
See more52W Range | $2.61-$7.07 |
Market Cap | $657.4M |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $465.2M |
Revenue Growth (YoY) | 31% |
Gross Profit (12 Mos) | $346.5M |
Diluted EPS | -$0.08 |
News
See moreYahoo Finance • 2 months ago
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
Yahoo Finance • 2 months ago
Organogenesis hits setback as second late-stage ReNu study misses key endpoint
Yahoo Finance • 2 months ago
Organogenesis Provides Update on Second Phase 3 ReNu® Study
Yahoo Finance • 3 months ago
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September
About
CEO | Mr. Gary S. Gillheeney Sr. |
Address | 85 Dan Road, Canton, MA, United States, 02021 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 869 |
